Bonk, Inc 8-K, filed Nov 30, 2020
Bonk, Inc. (BNKK)
About this 8-K
Bonk, Inc filed this 8-K on November 30, 2020.
Items reported
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 30, 2020
JUPITER WELLNESS, INC.
(Exact name of registrant as specified in charter)
| Delaware | 001-39569 | 83-2455880 | ||
| (State or other jurisdiction | (Commission | (IRS Employer | ||
| of incorporation) | File Number) | Identification No.) |
725 N. Hwy A1A, Suite C-106 Jupiter, FL 33477
(Address of principal executive offices) (Zip Code)
(561) 244-7100
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| [ ] | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| [ ] | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| [ ] | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| [ ] | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
| Common Stock | JUPW |
The Nasdaq Stock Market LLC (The Nasdaq Capital Market)
| ||
| Warrants, each exercisable for one share of Common Stock at $8.50 per share | JUPWW |
The Nasdaq Stock Market LLC (The Nasdaq Capital Market) |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company [X]
If an emerging growth company, indicate by check mart if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]
Item 7.01 Regulation FD Disclosure
On November 30, 2020 Jupiter Wellness, Inc. issued the attached press release. A copy of the press release is attached hereto and incorporated herein by reference in its entirety as Exhibit 99.1.
Item 9.01 Financial Statements and Exhibits
Exhibits
| Exhibit No. | Description | |
| 99.1 | Press release, dated November 30, 2020 |
| 1 |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: November 30, 2020
| JUPITER WELLNESS, INC. | ||
| By: | /s/ Brian John | |
| Brian John | ||
| Chief Executive Officer | ||
| 2 |
Jupiter Wellness, Inc. Discusses Focus on Proprietary Patent/Patent Pending CBD Sun Care and Skin Care Brands in New Video Interview on SNN Network
Los Angeles, CA – SNN Network, The Official Small-, Micro- and Nano-Cap News Source™, today published a new Video Interview with Brian John, CEO, and Dr. Glynn Wilson, Chairman and Chief Scientific Officer of Jupiter Wellness, Inc. (NASDAQ: JUPW), a developer of innovative sun care and skin care brands, according to the company’s website (see here: www.jupiterwellnessinc.com).
Click the following link to watch the Video Interview:
Jupiter Wellness' Focus on Proprietary Patent/Patent Pending CBD Sun Care and Skin Care Brands
(LINK WILL BE EMBEDDED ONCE VIDEO IS PUBLIC)
You can follow SNN Network on FACEBOOK, TWITTER, LINKEDIN, YOUTUBE
Please review important disclosures on our website at: http://stocknewsnow.com/legal.php#disclaimer
About Jupiter Wellness
Jupiter Wellness, Inc. (NASDAQ: JUPW) is a developer of innovative Suncare and Skin Care brands and other therapeutics with cannabinoids. The Company’s clinical pipeline of enhanced skin care therapeutics address indications including eczema, burns, HSV1 cold sores, and skin cancer. Jupiter generates revenues from a growing line of proprietary over-the-counter skincare products including CaniSun™ sunscreen and other wellness brands sold through its distribution platform.
For additional information, please visit www.JupiterWellnessinc.com www.Canisun.com.The Company’s public filings can be found at www.Sec.gov.
About SNN Network
SNN Network is an investor portal covering the Small-, Micro- and Nano-cap markets by providing news, insights, education tools and expert commentary. Subscribe now to our YouTube Channel to be notified when new CEO video interviews, Wall Street Views with investing experts, and Planet MicroCap Podcast episodes are available.
Subscribe NOW to SNN Network: http://bit.ly/1Q5Yfym
SNN Network
info@snnwire.com